GET DAILY SIGNALSSolesence (SLSN) Eyes the $1.00 Threshold (+11% Potential Move)
Key Takeaways
- The central target in this analysis is $1.00, roughly 11% above the most recent verified price near $0.90, based on a publicly discussed milestone rather than an analyst consensus.
- This target was established using the fallback method: the stock lacks meaningful numeric analyst price targets, so the $1.00 level is derived from the NASDAQ $1.00 minimum bid price requirement and the psychological "dollar" threshold.
- The required move from about $0.90 to $1.00 is a modest one, though micro-cap volatility means even small dollar moves can be percentage-large.
- Coverage is thin and cautious; published ratings are qualitative "Sell" or "Underperform" calls, with no credible individual price targets to aggregate.
- Supporting factors include the compliance significance of $1.00, a roughly $55 million revenue base, and growing consumer demand for mineral and "clean" skincare.
- The biggest risks are continued net losses, a thin cash position, an elevated debt-to-equity ratio, and the company's disclosed NASDAQ listing-deficiency status.
- For more context, explore the ticker's Major News, Today's Price Move, Forecast, and Earnings pages.
- Readers interested in AI-driven market monitoring can also explore Trending AI Robots.
How the $1.00 Target Came Into Focus
SLSN does not have a meaningful set of credible, current numeric analyst price targets to aggregate. MarketBeat reports a consensus price target of "N/A" with a single "Sell" rating on file, while Zacks Investment Research initiated coverage with an Underperform recommendation and Weiss Ratings has maintained a "Sell"-type qualitative rating. One third-party feed showing an extremely high "average target" is clearly a data-entry artifact and is excluded from this analysis.
Because no usable analyst targets exist, the central target is not an analyst consensus. Instead, it reflects a publicly discussed, verifiable milestone: the $1.00 level. NASDAQ generally requires listed companies to maintain a minimum closing bid price of $1.00, and Fidelity's quote page flags SLSN as having failed to meet NASDAQ continued listing requirements. Regaining and holding the $1.00 mark therefore carries concrete compliance significance beyond its role as a psychological round-number level. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Current Market Position and Path to $1.00
The most recent verified price for SLSN is approximately $0.90, with the stock trading in a 52-week range of roughly $0.61 to $3.17. Reaching $1.00 requires an upside of about 11%, a modest move by percentage standards but one that still demands sustained buying in a thinly traded micro-cap.
The path toward $1.00 likely runs through improved quarterly results and clearer progress on listing compliance. The company reports trailing-twelve-month revenue of about $55.4 million against a net loss of roughly $2.9 million, with diluted EPS of approximately -$0.04. A return to profitability, or at least a narrowing loss with revenue stabilization, would give investors a firmer fundamental basis to support the shares. From what I see, this remains the key variable to track.
Factors That Could Support the Move
The strongest support for a move to $1.00 is its dual role as a listing-compliance threshold and a psychological anchor. If management communicates a credible plan to regain NASDAQ compliance, investor attention could concentrate on that milestone. Solesence's positioning in mineral-based, "clean" skincare also aligns with durable consumer trends, and its proprietary Active Stress Defense technology provides differentiation in the sun-care and personal-care markets. A revenue base above $50 million shows the company is not a pre-revenue development-stage business, even if profitability remains elusive.
Risks That Could Keep the Stock Below $1.00
Several factors could keep the shares below $1.00. The company has posted net losses and carries negative EPS, with a thin cash balance of roughly $1.05 million and a debt-to-equity ratio near 172%, leaving limited financial cushion. The disclosed NASDAQ deficiency raises the risk of delisting proceedings if the bid price does not recover. As a micro-cap with low average volume, the stock is also vulnerable to sharp swings on modest trading activity, and the caution expressed in available ratings suggests sentiment remains skeptical.
Technical Levels Worth Watching
The $1.00 mark sits just above the current price and represents both a psychological level and a compliance threshold, making it a natural focal point. Below it, recent trading has found support in the $0.85–$0.86 area. The 52-week high near $3.17, reached in late 2025, underscores how far the stock has fallen, while the 52-week low near $0.61, set in mid-2026, marks the downside extreme. A sustained close above $1.00 would be a meaningful structural change, while repeated failure at that level could reinforce it as resistance. I’m watching this closely as the stock approaches that zone.
Time Horizon and Key Items to Monitor
Because the $1.00 target is tied to a listing-compliance milestone rather than a formal analyst research horizon, no single 12-month assumption applies. Investors should watch the company's next earnings release, scheduled for November 12, 2026, along with any statements from management about NASDAQ compliance, revenue trends, margin progress, and cash position. Corporate announcements regarding listing status and any reverse-stock-split considerations, which are common compliance tools, would be especially relevant to the $1.00 objective.
Exploring AI Daily Buy/Sell Signals
In my research process, I often review AI Daily Buy/Sell Signals to stay on top of shifting conditions in names like this one. These tools apply artificial intelligence to monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on market conditions, technical behavior, and AI-driven analysis. For a volatile micro-cap like SLSN, they can help identify changing trends more efficiently without manually reviewing every chart.
Using Tickeron AI Tools for Deeper Analysis
When evaluating micro-caps with limited analyst coverage, I turn to Tickeron’s suite of AI tools to cross-check trends and patterns. The AI Daily Buy/Sell Signals platform stands out for its ability to process real-time data and highlight potential momentum shifts. In practice, this has helped me monitor compliance-sensitive names more systematically alongside traditional fundamentals, offering an additional layer of perspective without replacing core due diligence.
Final Assessment
The question of whether Solesence (SLSN) can reach $1.00 is less about analyst conviction — there is effectively none to measure — and more about a compliance-driven, psychological milestone. At roughly $0.90, the required move is a modest 11%, but it must be achieved against continued losses, a thin cash position, high leverage, and a disclosed listing deficiency. The strongest supports are the concrete significance of $1.00 for NASDAQ compliance and the company's alignment with durable clean-skincare demand. The principal obstacles are financial fragility and weak sentiment. Investors should monitor earnings, listing-status communications, and whether the stock can hold above the $0.85 support zone, while recognizing that no outcome is guaranteed.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Aroon Indicator for SLSN shows an upward move is likely
SLSN's Aroon Indicator triggered a bullish signal on October 19, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 129 similar instances where the Aroon Indicator showed a similar pattern. In 109 of the 129 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on SLSN as a result. In 67 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for SLSN just turned positive on November 04, 2026. Looking at past instances where SLSN's MACD turned positive, the stock continued to rise in 34 of 49 cases over the following month. The odds of a continued upward trend are 69%.
SLSN moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for SLSN crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 63%.
Following a +6.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where SLSN advanced for three days, in 155 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
The 10-day RSI Indicator for SLSN moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In 21 of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 48 of 52 cases where SLSN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLSN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
SLSN broke above its upper Bollinger Band on October 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.604) is normal, around the industry mean (21.731). P/E Ratio (-21.430) is within average values for comparable stocks, (16.288). Projected Growth (PEG Ratio) (0.140) is also within normal values, averaging (1.518). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (1.139) is also within normal values, averaging (1.902).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. SLSN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLSN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HouseholdPersonalCare
Advertisement